I-Chlor Ophthalmic Solution en es it fr

I-Chlor Ophthalmic Solution Brand names, I-Chlor Ophthalmic Solution Analogs

I-Chlor Ophthalmic Solution Brand Names Mixture

  • No information avaliable

I-Chlor Ophthalmic Solution Chemical_Formula

C11H12Cl2N2O5

I-Chlor Ophthalmic Solution RX_link

http://www.rxlist.com/cgi/generic3/chloramphenicol.htm

I-Chlor Ophthalmic Solution fda sheet

I-Chlor_Ophthalmic_Solution FDA

I-Chlor Ophthalmic Solution msds (material safety sheet)

I-Chlor_Ophthalmic_Solution MSDS

I-Chlor Ophthalmic Solution Synthesis Reference

No information avaliable

I-Chlor Ophthalmic Solution Molecular Weight

323.129 g/mol

I-Chlor Ophthalmic Solution Melting Point

150.5 oC

I-Chlor Ophthalmic Solution H2O Solubility

2500 mg/L (at 25 °C)

I-Chlor Ophthalmic Solution State

Solid

I-Chlor Ophthalmic Solution LogP

1.476

I-Chlor Ophthalmic Solution Dosage Forms

Capsule; Drops; Liquid; Ointment; Powder; Solution; Suspension; Tablet

I-Chlor Ophthalmic Solution Indication

Used in treatment of cholera, as it destroys the vibrios and decreases the diarrhea. It is effective against tetracycline-resistant vibrios. It is also used in eye drops or ointment to treat bacterial conjunctivitis.

I-Chlor Ophthalmic Solution Pharmacology

Chloramphenicol is a broad-spectrum antibiotic that was derived from the bacterium Streptomyces venezuelae and is now produced synthetically. Chloramphenicol is effective against a wide variety of microorganisms, but due to serious side-effects (e.g., damage to the bone marrow, including aplastic anemia) in humans, it is usually reserved for the treatment of serious and life-threatening infections (e.g., typhoid fever). Chloramphenicol is bacteriostatic but may be bactericidal in high concentrations or when used against highly susceptible organisms. Chloramphenicol stops bacterial growth by binding to the bacterial ribosome (blocking peptidyl transferase) and inhibiting protein synthesis.

I-Chlor Ophthalmic Solution Absorption

Rapidly and completely absorbed from gastrointestinal tract following oral administration (bioavailability 80%). Well absorbed following intramuscular administration (bioavailability 70%). Intraocular and some systemic absorption also occurs after topical application to the eye.

I-Chlor Ophthalmic Solution side effects and Toxicity

Oral, mouse: LD50 = 1500 mg/kg; Oral, rat: LD50 = 2500 mg/kg. Toxic reactions including fatalities have occurred in the premature and newborn; the signs and symptoms associated with these reactions have been referred to as the gray syndrome. Symptoms include (in order of appearance) abdominal distension with or without emesis, progressive pallid cyanosis, vasomotor collapse frequently accompanied by irregular respiration, and death within a few hours of onset of these symptoms.

I-Chlor Ophthalmic Solution Patient Information

No information avaliable

I-Chlor Ophthalmic Solution Organisms Affected

Enteric bacteria and other eubacteria